CClinicalTrials.gg
CompletedNCT03049241LENGTH-FATIGUpdated Aug 7, 2026

Neuromuscular Fatigue Aetiology Comparison Between Prepubertal Boys and Adults

An observational study in Neuromuscular Fatigue, sponsored by University Hospital, Clermont-Ferrand. Completed at 1 site in France. Open to male participants aged 8 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-07.

Sponsored by University Hospital, Clermont-Ferrand · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
50
Ages
8 Years to 35 Years
Sex
Male
01

Study summary

Potential factors involved in neuromuscular fatigue were classified into two categories: 1) central factors involving the central nervous system and neural pathways, and 2) peripheral factors occurring within the muscle beyond the neuromuscular junction. In adults, it has been shown that peripheral factors contribute to a large part of the fatigue induced by repeated maximal contractions. However in children, central factors could account for the development of fatigue to a greater extent. Force-generating capacity and musculotendinous stiffness could be two of the discriminatory factors accounting for the differences in the neuromuscular fatigue between children and adults.

Force production capacity and musculotendinous stiffness vary as function of muscle length. Naturally, they could differ depending on the muscle groups studied. The main aim of the present protocol is to compare the effect of knee extensors and ankle plantarflexors length on the development and aetiology of neuromuscular fatigue, in children and adults. The investigators formulated the hypotheses that at short muscle length force and low musculotendinous stiffness, differences in force between children and adults would be reduced. Thus neuromuscular fatigue development and aetiology would be similar between both groups. The results of the present protocol will allow to better understanding of the aetiology of neuromuscular fatigue in children and help improving training or rehabilitation programs.

Read the detailed description

The study of neuromuscular fatigue in children is a recently topic in the field of sport sciences. Such knowledge could improve the efficiency and security of training and rehabilitation in healthy children and children with diseases like obesity.

The LENGTH-FATIG study will provide knowledge about the peripheral and central mechanisms of the neuromuscular fatigue in children and adults. Fatigue will test for different muscle groups (knee extensors and ankle plantar flexors) at different muscle lengths (short, optimal and long).

During high-intensity exercise, prepubertal children are more resistant to fatigue than adults. Contributions of the central and peripheral components to the development of neuromuscular fatigue are also different between both populations. The reduced children's fatigue coud be particularly related to a lower peripheral (i.e. muscular) fatigue. This might be attributed to the fact that prepubertal children rely more on oxidative than anaerobic metabolism than adults during fatiguing exercise. On the other hand, nervous factors could also explain differences in fatigue between children and adults. However, this topic is scarcely documented and still controversial. To our knowledge, no study has still compared the aetiology of central fatigue (supra-spinal vs. spinal) between children and adults. Only the voluntary activation level had been studied in children, conventionally used to assess central fatigue. But this factor doesn't differentiate spinal and supra-spinal contributions to neuromuscular fatigue development.

The LENGTH-FATIG research project is a physiological and observational study comparing two age groups (adults and children). Subjects will have to perform three randomized fatigue protocols at three muscle lengths (short, optimal and long) with the knee extensors and the ankle plantar flexors.

Data will be analyzed using LabChart 7.3 Pro software (ADInstrument, New South Wales, Australia) and Statistica 8.0 software (StatSoft, Inc.) and significance will be accepted at a two-sided alpha level of p\<.05. The normality and homogeneity of the variables will be checked respectively from a Shapiro-Wilk test and a Barlett test.

If normality and homogeneity of the variables are verified, absolute values of variables (Force, EMG, NIRS, etc.) will be compared using three factors (age x muscle length x muscle group) analyses of variance (ANOVA) with repeated measures. If analyses reveal a significant effect of any factor or interaction of factors, post-hoc Newman-Keuls tests will be performed to determine differences between the different conditions.

If, on the contrary, normality and homogeneity of the variables are not verified, the effects of muscle length, muscle group and age will be evaluated using a Friedman test. If the tests show significant effects, comparisons of the different conditions will be performed using Mann-Whitney and Wilcoxon tests.

02

Conditions studied

  • Neuromuscular Fatigue

Keywords

  • Children
  • Neuromuscular fatigue
  • Muscle group
  • Magnetic Nerve stimulation
  • Muscle length
  • Stiffness
  • prepubertal children
  • adults
03

In context

Lead sponsor

University Hospital, Clermont-Ferrand is the lead sponsor of 841 studies on the registry; 178 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 35 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

prepubertal boys and adults

Inclusion criteria

  • Boys aged 8 to 11 years old, Tanner stages 1 to 3
  • Male aged 18 to 35 years old
  • Non-smoker
  • Moderate physical activity level (\< 4h/week)
  • Covered by a social health insurance
  • Consent form signed by participants and/or legal guardians.

Exclusion criteria

Exclusion Criteria:

  • Competitive training
  • Cardiac or pulmonary diseases
  • Epileptic seizures past history
  • Magnetic field contraindication (including cardiac valve, pacemaker, prosthesis material, ferro-magnetic foreign body, cochlear implant and ocular prosthesis material.
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
50 participants (actual)
Patient registry
No

Groups and cohorts

  • knee extensors

    Other: neuromuscular fatigue

  • ankle plantar

    Other: neuromuscular fatigue

Interventions

  • Otherneuromuscular fatigue

    The main aim of the present protocol is to compare the effect of knee extensors and ankle plantarflexors length on the development and aetiology of neuromuscular fatigue, in children and adults

06

What researchers measure

Primary outcomes

  1. Maximal torque of knee extensors

    Time frame: once a week during six weeks.

  2. ankle plantar flexors joint (in N.m) measured with a dynamometer.

    Time frame: once a week during six weeks.

Secondary outcomes

  1. Doublet torque amplitude (100Hz, in N.m) evoked using magnetic nerve stimulation at rest

    Time frame: once a week during six weeks.

  2. Muscular tissue oxygenation (in μmol.L-1) measured at skin surface by Near-infrared spectroscopy.

    Time frame: once a week during six weeks

  3. Compound muscle action potential amplitude (i.e. M-wave ; in mV) evoked by supramaximal magnetic nerve stimulation and measured by surface Electromyography (EMG).

    Time frame: once a week during six weeks

  4. High frequency doublet (100Hz)/low frequency doublet (10Hz) ratio

    Time frame: once a week during six weeks

  5. fascicule length (mm) measured by B-mode real time ultrasound scanner.

    Time frame: once a week during six weeks

  6. pennation angle (degree) measured by B-mode real time ultrasound scanner.

    Time frame: once a week during six weeks

  7. Voluntary activation level (in %) assessed by using the twitch interpolation technique.

    Time frame: once a week during six weeks

  8. EMG signal Root mean square of EMG signal during isometric maximal voluntary contractions.

    Time frame: once a week during six weeks

  9. Hoffman reflex amplitude (i.e. H-reflex ; in mV) evoked by submaximal magnetic nerve stimulation measured by surface Electromyography (EMG).

    Time frame: once a week during six weeks

  10. Cerebral tissue oxygenation (in μmol.L-1) measured at skin surface by Near-infrared spectroscopy

    Time frame: once a week during six weeks

07

Study locations

1 site
  • CHU Clermont-Ferrand
    Clermont-Ferrand, 63003, France
08

References and documents

Publications

  • Piponnier E, Martin V, Bontemps B, Chalchat E, Julian V, Bocock O, Duclos M, Ratel S. Child-adult differences in neuromuscular fatigue are muscle dependent. J Appl Physiol (1985). 2018 Oct 1;125(4):1246-1256. doi: 10.1152/japplphysiol.00244.2018. Epub 2018 Aug 9. PubMed 30091669 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03049241
Lead sponsor
University Hospital, Clermont-Ferrand
Collaborators
Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques
Responsible party
Sponsor
First posted
Feb 10, 2017
Start date
Feb 13, 2017
Primary completion
Nov 20, 2017
Completion
Nov 20, 2017
Last update
Aug 7, 2026

Study contacts

Martine DUCLOS
principal investigator · University Hospital, Clermont-Ferrand
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion